Traders sold shares of Humana Inc. (NYSE:HUM) on strength during trading hours on Tuesday. $50.55 million flowed into the stock on the tick-up and $84.02 million flowed out of the stock on the tick-down, for a money net flow of $33.47 million out of the stock. Of all equities tracked, Humana had the 0th highest net out-flow for the day. Humana traded up $3.92 for the day and closed at $253.28

A number of equities research analysts recently commented on HUM shares. Citigroup Inc. started coverage on Humana in a research note on Wednesday, June 28th. They set a “buy” rating and a $275.00 price objective for the company. Zacks Investment Research raised Humana from a “hold” rating to a “buy” rating and set a $256.00 price objective for the company in a research note on Monday, May 8th. BidaskClub raised Humana from a “hold” rating to a “buy” rating in a research note on Wednesday, June 21st. Jefferies Group LLC reaffirmed a “hold” rating and set a $230.00 price objective (up from $221.00) on shares of Humana in a research note on Thursday, May 4th. Finally, Argus raised Humana from a “hold” rating to a “buy” rating and set a $260.00 price objective for the company in a research note on Friday, June 9th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $244.35.

The stock has a market cap of $36.42 billion, a P/E ratio of 20.73 and a beta of 0.91. The company’s 50 day moving average price is $242.00 and its 200 day moving average price is $225.90.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The company had revenue of $13.53 billion for the quarter, compared to analyst estimates of $13.61 billion. During the same quarter last year, the firm earned $2.30 EPS. Equities research analysts anticipate that Humana Inc. will post $11.55 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Tuesday, August 29th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.63%. The ex-dividend date is Thursday, September 28th. Humana’s payout ratio is presently 13.06%.

In other news, VP Heidi S. Margulis sold 1,500 shares of Humana stock in a transaction that occurred on Friday, May 26th. The stock was sold at an average price of $231.96, for a total transaction of $347,940.00. Following the sale, the vice president now owns 8,150 shares of the company’s stock, valued at approximately $1,890,474. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Brian P. Leclaire sold 4,971 shares of Humana stock in a transaction that occurred on Wednesday, June 28th. The stock was sold at an average price of $240.00, for a total value of $1,193,040.00. Following the sale, the senior vice president now directly owns 14,258 shares in the company, valued at approximately $3,421,920. The disclosure for this sale can be found here. Insiders have sold a total of 41,406 shares of company stock worth $10,355,086 in the last three months. 0.80% of the stock is owned by insiders.

Several hedge funds have recently made changes to their positions in HUM. Creative Planning raised its stake in shares of Humana by 0.3% in the second quarter. Creative Planning now owns 4,874 shares of the insurance provider’s stock valued at $1,173,000 after buying an additional 15 shares during the last quarter. ProShare Advisors LLC raised its stake in shares of Humana by 15.8% in the first quarter. ProShare Advisors LLC now owns 17,297 shares of the insurance provider’s stock valued at $3,566,000 after buying an additional 2,356 shares during the last quarter. US Bancorp DE raised its stake in shares of Humana by 4.4% in the second quarter. US Bancorp DE now owns 44,359 shares of the insurance provider’s stock valued at $10,674,000 after buying an additional 1,870 shares during the last quarter. CHURCHILL MANAGEMENT Corp purchased a new stake in shares of Humana during the second quarter valued at $6,074,000. Finally, Oppenheimer & Co. Inc. raised its stake in shares of Humana by 1.1% in the first quarter. Oppenheimer & Co. Inc. now owns 18,830 shares of the insurance provider’s stock valued at $3,882,000 after buying an additional 203 shares during the last quarter. 99.13% of the stock is currently owned by institutional investors.

WARNING: This article was originally posted by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://www.dailypolitical.com/2017/08/24/traders-sell-shares-of-humana-inc-hum-on-strength-hum-4.html.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.